BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 25737132)

  • 1. Optimization Studies on Prokaryotic Cell Expression of the Human Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand (TRAIL).
    Hao L; Zhang ZG; Shi ZD; Pang K; Zhang JJ; Dong Y; Han CH
    Cell Biochem Biophys; 2015 Nov; 73(2):275-279. PubMed ID: 25737132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cloning, expression and purification of human TNF-related apoptosis-inducing ligand in Escherichia coli].
    Yao GH; Luan JF; Ye D; Lei QH; Zhu PY; Jin J; Hou YY
    Wei Sheng Yan Jiu; 2006 Nov; 35(6):697-700. PubMed ID: 17290744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-level expression, purification, and in vitro refolding of soluble tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
    Wang D; Shi L
    Appl Biochem Biotechnol; 2009 Apr; 157(1):1-9. PubMed ID: 19306078
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression and refolding of thioredoxin/TRAIL fusion from inclusion bodies and further purification of TRAIL after cleavage by enteropeptidase.
    Gasparian ME; Ostapchenko VG; Yagolovich AV; Tsygannik IN; Chernyak BV; Dolgikh DA; Kirpichnikov MP
    Biotechnol Lett; 2007 Oct; 29(10):1567-73. PubMed ID: 17609857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Expression and purification of truncated fragment of extracellular segment of sodium pump alpha3 subunit in Escherichia coli by in-fusion technology].
    Zhang MJ; Yang J; Zhu CZ; Duan ZM; Niu XL; Wang R; Song YF
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Mar; 40(2):203-7. PubMed ID: 19462890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimization of expression and purification of two biologically active chimeric fusion proteins that consist of human interleukin-13 and Pseudomonas exotoxin in Escherichia coli.
    Joshi BH; Puri RK
    Protein Expr Purif; 2005 Feb; 39(2):189-98. PubMed ID: 15642470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cloning, prokaryotic expression, and antigenicity identification of extracellular domain of mouse CD40].
    Tian R; Zhu J; Yin X; Wang W; Lin X; Xu Y; Yan J; Zhang W; Gao J; Yu J
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2013 Nov; 29(11):1200-4. PubMed ID: 24200070
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional identification of a non-fusion TRAIL extracellular protein and preparation of its polyclonal antibody.
    Zhao K; Wang X; Wang Y; Ma Y
    Hybridoma (Larchmt); 2011 Jun; 30(3):217-21. PubMed ID: 21707355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression, purification and renaturation of truncated human integrin β1 from inclusion bodies of Escherichia coli.
    Shi T; Zhang L; Li Z; Newton IP; Zhang Q
    Protein Expr Purif; 2015 Mar; 107():13-9. PubMed ID: 25462808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Construction of prokaryotic expression plasmid pET15b-PEP-1-CAT and expression and purification of PEP-1-CAT fusion protein].
    Yao LL; Wang JN; Huang YZ; Guo LY
    Nan Fang Yi Ke Da Xue Xue Bao; 2006 Sep; 26(9):1319-25. PubMed ID: 16982446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression, purification, and in vitro refolding of soluble tumor necrosis factor-related apoptosis-inducing ligand (TRAIL).
    Lin Z; Lei H; Cao P
    Protein Expr Purif; 2007 Feb; 51(2):276-82. PubMed ID: 17079165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Expression and purification of recombinant Trail protein in E.coli and the optimal conditions for Trail purification].
    Cai YY; Li XY; Wu Y; DU JC; Xu X
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Jun; 28(6):596-600. PubMed ID: 22691351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prokaryotic expression, purification and identification of VEGFR2 D3.4/GST fusion protein in E.coli].
    Wei YY; Song CJ; Sun YJ; Gong JY; Jin BQ; Yang AG; Yang K
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Sep; 24(9):870-2. PubMed ID: 18782519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Refolding and purification of Plasmodium falciparum glutamate dehydrogenase fusion protein].
    Li Y; Ning YS; Hao WB; Li L; Li M
    Di Yi Jun Yi Da Xue Xue Bao; 2003 Dec; 23(12):1273-6. PubMed ID: 14678888
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simplified method for the efficient purification and refolding of recombinant human TRAIL.
    Zhang Z; Hahn SB; Cao TM; King MR
    Biotechnol Prog; 2020 Sep; 36(5):e3007. PubMed ID: 32329219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Target cell-restricted apoptosis induction by 528scFv-TRAIL fusion protein specific for human EGFR and expressed in Escherichia coli.
    Badran A; Asano R; Nakayama M; Watanabe Y; Nakanishi T; Umetsu M; Hayashi H; Katayose Y; Unno M; Kumagai I
    Int J Oncol; 2010 May; 36(5):1229-34. PubMed ID: 20372797
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intein-mediated fusion expression, high efficient refolding, and one-step purification of gelonin toxin.
    Guo C; Li Z; Shi Y; Xu M; Wise JG; Trommer WE; Yuan J
    Protein Expr Purif; 2004 Oct; 37(2):361-7. PubMed ID: 15358358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression and purification of human sucrase protein in E.coli].
    Shao M; Wang X; Zhang Q; Niu X; Wang Y; Zhou H; Ge Z
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Dec; 31(12):1629-32. PubMed ID: 26648296
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prokaryotic expression, purification and identification of NY-ESO-1/GST fusion protein in E.coli].
    Tang L; Song CJ; Sun YJ; Li N; Wei YY; Sun Y; Yang K
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 Oct; 28(10):1094-7. PubMed ID: 23046942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Strategy for linker selection to enhance refolding and bioactivity of VAS-TRAIL fusion protein based on inclusion body conformation and activity.
    Fan J; Huang L; Sun J; Qiu Y; Zhou J; Shen Y
    J Biotechnol; 2015 Sep; 209():16-22. PubMed ID: 26072465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.